Dr. Rajesh Pahwa, MD

Dr. Pahwa practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Pahwa's NPI, 1255438164, was assigned on September 20, 2006. Dr. Pahwa holds Kansas license 04-23597.

Dr. Pahwa's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Pahwa's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Pahwa is also affiliated with AdventHealth Shawnee Mission. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Pahwa to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pahwa practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pahwa's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Pahwa is licensed in Kansas.

CMS data shows 1,590 Medicare services from Dr. Pahwa across 7 procedure codes in 2024, for 557 Medicare patients. Medicare paid $78,825 for them. Every service was in an office.

CMS counts 557 Medicare patients who saw Dr. Pahwa in 2024. The largest group is 75 to 84, with 262 patients. 75% of them have parkinson's disease, and 70% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pahwa's median patient age at 75, with 38% women.

In 2024, Dr. Pahwa wrote 10,065 Medicare Part D claims for 685 patients. 86% of them were for generic drugs. CMS names the drug for 9,909 of them, across 71 drugs with 11 or more claims each, at $4,644,180 in total drug cost. In 2023, CMS named 9,471 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pahwa for performance year 2024, reported through an alternative payment model (APM). Dr. Pahwa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pahwa as offering telehealth.

Dmand AI links 102 papers to Dr. Pahwa, published from 2014 to 2025. 2022 was the busiest year, with 12. The most frequent topics are Parkinson Disease, Levodopa and Antiparkinson Agents. Dr. Pahwa has published most often in Clin Park Relat Disord. Dr. Pahwa's most frequent co-authors are Stuart H. Isaacson, MD, Robert A. Hauser, MD and Caroline M. Tanner, MD, PhD.

CMS Open Payments shows 1,527 general payments to Dr. Pahwa from 38 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. ACADIA Pharmaceuticals Inc paid the most, $308,010. It also lists 5 research payments totaling $8,656 from 2018 to 2020.